MENU
+Compare
TRDA
Stock ticker: NASDAQ
AS OF
Nov 28 closing price
Price
$10.27
Change
+$0.19 (+1.88%)
Capitalization
385.63M

TRDA Entrada Therapeutics Forecast, Technical & Fundamental Analysis

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

TRDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for TRDA with price predictions
Nov 28, 2025

Momentum Indicator for TRDA turns positive, indicating new upward trend

TRDA saw its Momentum Indicator move above the 0 level on November 11, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 74 similar instances where the indicator turned positive. In of the 74 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for TRDA just turned positive on November 10, 2025. Looking at past instances where TRDA's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where TRDA advanced for three days, in of 255 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 144 cases where TRDA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRDA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TRDA broke above its upper Bollinger Band on November 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TRDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.152) is normal, around the industry mean (27.168). P/E Ratio (10.259) is within average values for comparable stocks, (52.496). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.897). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (6.974) is also within normal values, averaging (334.447).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
TRDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

TRDA is expected to report earnings to fall 6.60% to -99 cents per share on March 18

Entrada Therapeutics TRDA Stock Earnings Reports
Q4'25
Est.
$-0.99
Q3'25
Missed
by $0.07
Q2'25
Missed
by $0.22
Q1'25
Beat
by $0.31
Q4'24
Beat
by $0.70
The last earnings report on November 06 showed earnings per share of -105 cents, missing the estimate of -99 cents. With 141.41K shares outstanding, the current market capitalization sits at 385.63M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Design Center Place
Phone
+1 857 520-9158
Employees
159
Web
https://www.entradatx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCSSX37.890.09
+0.24%
NYLI WMC Enduring Capital Investor Class
TOECX40.25N/A
N/A
Touchstone Mid Cap Growth C
ANORX20.59N/A
N/A
American Century Small Cap Growth R
SEPCX9.78N/A
N/A
Saratoga Energy & Basic Materials C
BHCUX22.04-0.08
-0.35%
Baron Health Care R6

TRDA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with NRIX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+1.88%
NRIX - TRDA
50%
Loosely correlated
+2.79%
IDYA - TRDA
49%
Loosely correlated
-0.72%
SYRE - TRDA
48%
Loosely correlated
+0.84%
CRNX - TRDA
48%
Loosely correlated
-1.02%
RARE - TRDA
47%
Loosely correlated
+2.93%
More